Prestige Consumer Healthcare Inc. · NYSE:PBH
Prestige Consumer Healthcare — Q3 FY2021 Earnings Presentation
19 slides from Prestige Consumer Healthcare's earnings presentation, Feb 4, 2021
Slide 1: Third Quarter FY 2021 Results
Third Quarter FY 2021 Results February 4th, 2021 Exhibit 99.2
Slide 2: Safe Harbor Disclosure
T H I R D Q U A R T E R F Y 2 1 R E S U L T S This presentation contains certain “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995, such as statements regarding the Company’s expected financial performance, including revenues, EPS, free cash flow
Slide 3: Agenda for Today's Discussion
T H I R D Q U A R T E R F Y 2 1 R E S U L T S Agenda for Today’s Discussion I. Strategic Priorities II. Financial Overview III. FY 21 Outlook 3
Slide 4: I. Strategic Priorities
T H I R D Q U A R T E R F Y 2 1 R E S U L T S I. Strategic Priorities
Slide 5: Strategy in Place for Value Creation
T H I R D Q U A R T E R F Y 2 1 R E S U L T S Strategy in Place for Value Creation Strategy and Execution is Delivering Results Long-Term Strategy ◼ Brand-building designed to grow categories and connect with consumers ◼ Strategy and tactics performing well in an evolving environment Business Contin
Slide 6: Compound W: Proven Success Executing Against our Playbook
T H I R D Q U A R T E R F Y 2 1 R E S U L T S 6 Compound W: Proven Success Executing Against our Playbook Innovation eCommerce Investments Shelf-Space Wins ~$61M Retail Sales(2) Innovation and Superior Product Expand Leading Position Consumer Content * CAGR represents the period from 2015 to 2020
Slide 7: II. Financial Overview
T H I R D Q U A R T E R F Y 2 1 R E S U L T S II. Financial Overview
Slide 8: Key Financial Results for Third Quarter and YTD FY 21
T H I R D Q U A R T E R F Y 2 1 R E S U L T S Key Financial Results for Third Quarter and YTD FY 21 Performance FY 21 FY 20 Dollar values in millions, except per share data. $238.8 $ 81.4 $0.81 $241.6 $86.9 $0.81 Revenue Adjusted EBITDA Adjusted EPS (1.1%) (6.3%) 0.0% 8 Q 3 $705.6 $249.7 $2.45 $711.
Slide 9: Third Quarter and YTD Consolidated Financial Summary
T H I R D Q U A R T E R F Y 2 1 R E S U L T S Q3 FY 21 Q3 FY 20 % Chg YTD FY 21 YTD FY 20 % Chg Total Revenue 238.8$ 241.6$ (1.1%) 705.6$ 711.8$ (0.9%) Adj. Gross Margin (3) 138.9 140.1 (0.8%) 410.4 412.3 (0.5%) % Margin 58.2% 58.0% 58.2% 57.9% A&M 38.1 33.6 13.5% 104.2 107.0 (2.7%) % Total Revenue
Slide 10: Industry Leading Free Cash Flow Trends
T H I R D Q U A R T E R F Y 2 1 R E S U L T S $43.5 $159.2 $56.3 $154.3 Adj. Free Cash Flow Adj. Free Cash Flow Free Cash Flow(3) Comments ◼ YTD FY 21 Free Cash Flow of $159.2 million up 3.2% vs. PY – Q3 Free Cash Flow down vs. PY due to CapEx and working capital timing – Continue to anticipate incr
Slide 11: III. FY 21 Outlook
T H I R D Q U A R T E R F Y 2 1 R E S U L T S III. FY 21 Outlook
Slide 12: Outlook: Staying the Course to Create Value
T H I R D Q U A R T E R F Y 2 1 R E S U L T S Outlook: Staying the Course to Create Value ◼ Strategy intact with stable and well-positioned business ◼ Market share solid and growing during pandemic environment ◼ Anticipate FY 21 Revenue of approximately $935 million ◼ Increasing FY 21 Adjusted EPS(5
Slide 13: Q&A
T H I R D Q U A R T E R F Y 2 1 R E S U L T S Q&A
Slide 14: Appendix
T H I R D Q U A R T E R F Y 2 1 R E S U L T S Appendix (1) Organic Revenue is a Non-GAAP financial measure and is reconciled to the most closely related GAAP financial measure in the attached Reconciliation Schedules and / or our earnings release dated February 4, 2021 in the “About Non-GAAP Financi
Slide 15: Adjusted Gross Margin Reconciliation Schedules
T H I R D Q U A R T E R F Y 2 1 R E S U L T S Adjusted Gross Margin 15 Reconciliation Schedules Organic Revenue Change a) Items related to new warehouse represent costs to transition to the new warehouse and duplicate costs incurred during the transition. Three Months Ended December 31, Nine Months
Slide 16: Reconciliation Schedules (Continued): Adjusted EBITDA Margin
T H I R D Q U A R T E R F Y 2 1 R E S U L T S 16 Reconciliation Schedules (Continued) Adjusted EBITDA Margin a) Items related to new warehouse represent costs to transition to the new warehouse and duplicate costs incurred during the transition. Three Months Ended December 31, Nine Months Ended Dece
Slide 17: Reconciliation Schedules (Continued): Adjusted Net Income & Adjusted EPS
T H I R D Q U A R T E R F Y 2 1 R E S U L T S 17 Reconciliation Schedules (Continued) Adjusted Net Income & Adjusted EPS Note: Amounts may not add due to rounding. a) Items related to new warehouse represent costs to transition to the new warehouse and duplicate costs incurred during the transition.
Slide 18: Reconciliation Schedules (Continued): Adjusted Free Cash Flow
T H I R D Q U A R T E R F Y 2 1 R E S U L T S 18 Reconciliation Schedules (Continued) Adjusted Free Cash Flow a) Payments related to new warehouse represent costs to transition to the new warehouse and duplicate costs incurred during transition. Three Months Ended December 31, Nine Months Ended Dece
Slide 19: Projected Free Cash Flow and Projected EPS Reconciliation
T H I R D Q U A R T E R F Y 2 1 R E S U L T S Projected Free Cash Flow 19 Reconciliation Schedules (Continued) Projected EPS a) Income tax adjustment to adjust for discrete income tax items. Projected FY'21 GAAP EPS 3.32$ Adjustments: Normalized tax rate adjustment for discrete income tax items (a)
Prestige Consumer Healthcare — Q3 FY2021 Earnings Presentation on 6ix